» Articles » PMID: 8374249

Immunological Features of Sporadic Multinodular Goiter

Overview
Journal Clin Investig
Specialty General Medicine
Date 1993 Jul 1
PMID 8374249
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The origin of sporadic multinodular goiter is still uncertain. To obtain information on a number of unexplored immunological features, the distribution and characterization of T, B, and natural killer lymphocyte subsets were studied in the peripheral blood of 15 patients with multinodular goiter; 8 patients with Graves' disease (for reference purposes with a well-characterized autoimmune disease) and 29 age- and sex-matched healthy controls, combining double-staining immunofluorescence technique with monoclonal antibodies and flow cytometry. Although in both thyroid diseases increased CD3+ HLA-DR+ activated T cells (P < 0.01) were detected, in Graves' disease this was associated with decreased numbers of CD8 cells (P < 0.05) and an increased CD4/CD8 ratio (P < 0.01). These abnormalities were absent in multinodular goiter, which displayed increased CD8+ CD57+ cytotoxic/suppressor cells (P < 0.01). There was an increase in the percentage of natural killer cells expressing CD16 and CD57 antigens in multinodular goiter but not in Graves' disease. The B-cell associated antigens CD19 and CD19+ CD5+ were significantly increased in Graves' disease (P < 0.01), while the multinodular goiter patients exhibited only an increased number of B cells coexpressing the CD5 antigen (CD19+ CD5+), which was unrelated to the titers of anti-microsomal and antithyroglobulin autoantibodies. Our results point to the presence of several abnormalities of peripheral T, B, and natural killer lymphocytes in sporadic multinodular goiter, with a distribution pattern quite different from that observed in Graves' disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases.

Martinez-Orozco F, Fernandez-Arquero M, Vicario J, Lillo-Triguero L, Ameyugo E, Peraita-Adrados R J Clin Med Res. 2022; 14(8):309-314.

PMID: 36128006 PMC: 9451554. DOI: 10.14740/jocmr4758.


Thyroidal Transcriptomic Profiles of Pathoadaptive Responses to Congenital Hypothyroidism in XB130 Knockout Mice.

Sugihara J, Wong A, Shimizu H, Zhao J, Cho H, Wang Y Cells. 2022; 11(6).

PMID: 35326426 PMC: 8947158. DOI: 10.3390/cells11060975.


Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.

Martinez-Orozco F, Vicario J, de Andres C, Fernandez-Arquero M, Peraita-Adrados R J Clin Med Res. 2016; 8(7):495-505.

PMID: 27298657 PMC: 4894018. DOI: 10.14740/jocmr2569w.


Status of antithyroid antibodies in Bangladesh.

Hasanat M, Rumi M, Alam M, Hasan K, Salimullah M, Salam M Postgrad Med J. 2000; 76(896):345-9.

PMID: 10824048 PMC: 1741600. DOI: 10.1136/pmj.76.896.345.

References
1.
Corrales J, Tabernero J, Miralles J, Hernandez M . Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiter. Klin Wochenschr. 1991; 69(1):19-24. DOI: 10.1007/BF01649051. View

2.
Doniach D, HUDSON R, Roitt I . Human auto-immune thyroiditis: clinical studies. Br Med J. 1960; 1(5170):365-73. PMC: 1966620. DOI: 10.1136/bmj.1.5170.365. View

3.
Ludgate M, McGregor A, Weetman A, Ratanachaiyavong S, Lazarus J, Hall R . Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Br Med J (Clin Res Ed). 1984; 288(6416):526-30. PMC: 1444553. DOI: 10.1136/bmj.288.6416.526. View

4.
Robertson M, Ritz J . Biology and clinical relevance of human natural killer cells. Blood. 1990; 76(12):2421-38. View

5.
Jansson R, Karlsson A, Forsum U . Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol. 1984; 58(2):264-72. PMC: 1577052. View